NCT02734316View on ClinicalTrials.gov

Management of Direct Oral Anti-Coagulants (DOACs) for Gastrointestinal Endoscopy Procedures

CompletedOBSERVATIONAL
Enrollment

531

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Anticoagulant Disorders
Interventions
OTHER

endoscopic procedure

Evaluation of adverse events in patients on DOACs undergoing GI endoscopy

Trial Locations (1)

22100

Valduce Hospital, Como

All Listed Sponsors
lead

Valduce Hospital

OTHER

NCT02734316 - Management of Direct Oral Anti-Coagulants (DOACs) for Gastrointestinal Endoscopy Procedures | Biotech Hunter | Biotech Hunter